These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 36908896)

  • 1. Capillary function progressively deteriorates in prodromal Alzheimer's disease: A longitudinal MRI perfusion study.
    Madsen LS; Nielsen RB; Parbo P; Ismail R; Mikkelsen IK; Gottrup H; Østergaard L; Brooks DJ; Eskildsen SF
    Aging Brain; 2022; 2():100035. PubMed ID: 36908896
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impaired perfusion and capillary dysfunction in prodromal Alzheimer's disease.
    Nielsen RB; Parbo P; Ismail R; Dalby R; Tietze A; Brændgaard H; Gottrup H; Brooks DJ; Østergaard L; Eskildsen SF
    Alzheimers Dement (Amst); 2020; 12(1):e12032. PubMed ID: 32490139
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Capillary dysfunction correlates with cortical amyloid load in early Alzheimer's disease.
    Madsen LS; Parbo P; Ismail R; Gottrup H; Østergaard L; Brooks DJ; Eskildsen SF
    Neurobiol Aging; 2023 Mar; 123():1-9. PubMed ID: 36610198
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oh brother, where art tau? Amyloid, neurodegeneration, and cognitive decline without elevated tau.
    McCollum LE; Das SR; Xie L; de Flores R; Wang J; Xie SX; Wisse LEM; Yushkevich PA; Wolk DA;
    Neuroimage Clin; 2021; 31():102717. PubMed ID: 34119903
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The relationships between neuroinflammation, beta-amyloid and tau deposition in Alzheimer's disease: a longitudinal PET study.
    Ismail R; Parbo P; Madsen LS; Hansen AK; Hansen KV; Schaldemose JL; Kjeldsen PL; Stokholm MG; Gottrup H; Eskildsen SF; Brooks DJ
    J Neuroinflammation; 2020 May; 17(1):151. PubMed ID: 32375809
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased cortical capillary transit time heterogeneity in Alzheimer's disease: a DSC-MRI perfusion study.
    Eskildsen SF; Gyldensted L; Nagenthiraja K; Nielsen RB; Hansen MB; Dalby RB; Frandsen J; Rodell A; Gyldensted C; Jespersen SN; Lund TE; Mouridsen K; Brændgaard H; Østergaard L
    Neurobiol Aging; 2017 Feb; 50():107-118. PubMed ID: 27951412
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Imaging characteristic of dual-phase (18)F-florbetapir (AV-45/Amyvid) PET for the concomitant detection of perfusion deficits and beta-amyloid deposition in Alzheimer's disease and mild cognitive impairment.
    Lin KJ; Hsiao IT; Hsu JL; Huang CC; Huang KL; Hsieh CJ; Wey SP; Yen TC
    Eur J Nucl Med Mol Imaging; 2016 Jul; 43(7):1304-14. PubMed ID: 27003417
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The structural MRI markers and cognitive decline in prodromal Alzheimer's disease: a 2-year longitudinal study.
    Wei H; Kong M; Zhang C; Guan L; Ba M;
    Quant Imaging Med Surg; 2018 Nov; 8(10):1004-1019. PubMed ID: 30598878
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Capillary dysfunction is associated with symptom severity and neurodegeneration in Alzheimer's disease.
    Nielsen RB; Egefjord L; Angleys H; Mouridsen K; Gejl M; Møller A; Brock B; Brændgaard H; Gottrup H; Rungby J; Eskildsen SF; Østergaard L
    Alzheimers Dement; 2017 Oct; 13(10):1143-1153. PubMed ID: 28343848
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MRI-based Alzheimer's disease-resemblance atrophy index in the detection of preclinical and prodromal Alzheimer's disease.
    Liu W; Au LWC; Abrigo J; Luo Y; Wong A; Lam BYK; Fan X; Kwan PWL; Ma HW; Ng AYT; Chen S; Leung EYL; Ho CL; Wong SHM; Chu WC; Ko H; Lau AYL; Shi L; Mok VCT;
    Aging (Albany NY); 2021 May; 13(10):13496-13514. PubMed ID: 34091443
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cognitive impairment in late-life bipolar disorder is not associated with Alzheimer's disease pathological signature in the cerebrospinal fluid.
    Forlenza OV; Aprahamian I; Radanovic M; Talib LL; Camargo MZ; Stella F; Machado-Vieira R; Gattaz WF
    Bipolar Disord; 2016 Feb; 18(1):63-70. PubMed ID: 26876913
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heterogeneity of Amyloid Binding in Cognitively Impaired Patients Consecutively Recruited from a Memory Clinic: Evaluating the Utility of Quantitative 18F-Flutemetamol PET-CT in Discrimination of Mild Cognitive Impairment from Alzheimer's Disease and Other Dementias.
    Bao YW; Chau ACM; Chiu PK; Shea YF; Kwan JSK; Chan FHW; Mak HK
    J Alzheimers Dis; 2021; 79(2):819-832. PubMed ID: 33361593
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Trajectory of Cerebrospinal Fluid Growth-Associated Protein 43 in the Alzheimer's Disease Continuum: A Longitudinal Study.
    Zhang H; Lyu D; Jia J;
    J Alzheimers Dis; 2022; 85(4):1441-1452. PubMed ID: 34958042
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between Cerebral Perfusion on Arterial Spin Labeling (ASL) MRI with Brain Volumetry and Cognitive Performance in Mild Cognitive Impairment and Dementia due to Alzheimer's Disease.
    Soman S; Raghavan S; Rajesh PG; Varma RP; Mohanan N; Ramachandran SS; Thomas B; Kesavadas C; Menon RN
    Ann Indian Acad Neurol; 2021; 24(4):559-565. PubMed ID: 34728951
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cerebral Blood Flow Predicts Conversion of Mild Cognitive Impairment into Alzheimer's Disease and Cognitive Decline: An Arterial Spin Labeling Follow-up Study.
    Duan W; Zhou GD; Balachandrasekaran A; Bhumkar AB; Boraste PB; Becker JT; Kuller LH; Lopez OL; Gach HM; Dai W
    J Alzheimers Dis; 2021; 82(1):293-305. PubMed ID: 34024834
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ApoE4 effects on automated diagnostic classifiers for mild cognitive impairment and Alzheimer's disease.
    Apostolova LG; Hwang KS; Kohannim O; Avila D; Elashoff D; Jack CR; Shaw L; Trojanowski JQ; Weiner MW; Thompson PM;
    Neuroimage Clin; 2014; 4():461-72. PubMed ID: 24634832
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MRI and CSF studies in the early diagnosis of Alzheimer's disease.
    de Leon MJ; DeSanti S; Zinkowski R; Mehta PD; Pratico D; Segal S; Clark C; Kerkman D; DeBernardis J; Li J; Lair L; Reisberg B; Tsui W; Rusinek H
    J Intern Med; 2004 Sep; 256(3):205-23. PubMed ID: 15324364
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Regression analysis of cerebral blood perfusion and cognitive function in patients with mild cognitive impairment and Alzheimer's disease].
    Xu Y; Chen LL; Su Y; Sun SN; Zhang HY
    Zhonghua Yi Xue Za Zhi; 2019 Jan; 99(3):193-197. PubMed ID: 30669762
    [No Abstract]   [Full Text] [Related]  

  • 19. Stage-specific links between plasma neurofilament light and imaging biomarkers of Alzheimer's disease.
    Benedet AL; Leuzy A; Pascoal TA; Ashton NJ; Mathotaarachchi S; Savard M; Therriault J; Kang MS; Chamoun M; Schöll M; Zimmer ER; Gauthier S; Labbe A; Zetterberg H; Rosa-Neto P; Blennow K;
    Brain; 2020 Dec; 143(12):3793-3804. PubMed ID: 33210117
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased plasma TACE activity in subjects with mild cognitive impairment and patients with Alzheimer's disease.
    Sun Q; Hampel H; Blennow K; Lista S; Levey A; Tang B; Li R; Shen Y
    J Alzheimers Dis; 2014; 41(3):877-86. PubMed ID: 24685635
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.